Tricyclic benzazepine vasopressin antagonists
US5700796A · kind A · utility
12Cited by
5References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 1996 |
| Grant date | Dec 23, 1997 |
| Priority date | — |
| Expiry date | Jun 27, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Tricyclic compound of the general Formula I: ##STR1## as defined herein which exhibit antagonist activity at V.sub.1 and/or V.sub.2 receptors and exhibit in vivo vasopressin antagonist activity, methods for using such compounds in treating diseases characterized by excess renal reabsorption of water, and process for preparing such compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.